首页 | 本学科首页   官方微博 | 高级检索  
     


Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors
Affiliation:1. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France;2. Department of Medicine, Institut Bergonié, Bordeaux, France;3. Explicyte Immuno-Oncology, Bordeaux, France;4. University of Bordeaux, Bordeaux, France;5. Department of Biopathology, Institut Bergonié, Bordeaux, France;6. Laboratory of Immunomonitoring in Oncology, Gustave Roussy, Villejuif, France;7. University Paris-Saclay, UFR Pharmacy, Chatenay-Malabry, France;8. Department of Medical Oncology, Gustave Roussy, Villejuif, France;9. Department of Interventional Radiology, Gustave Roussy, Villejuif, France, INSERM U981, Gustave Roussy, Villejuif, France
Abstract:
Keywords:arginine metabolism  cancer immunotherapy  immune checkpoint inhibitor  biomarker
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号